Renaissance Technologies’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-95,400
| Closed | -$340K | – | 3441 |
|
|
2024
Q4 | $340K | Buy |
95,400
+66,800
| +234% | +$238K | ﹤0.01% | 2994 |
|
|
2024
Q3 | $142K | Sell |
28,600
-467,600
| -94% | -$2.33M | ﹤0.01% | 3191 |
|
|
2024
Q2 | $1.29M | Sell |
496,200
-879,600
| -64% | -$2.29M | ﹤0.01% | 2174 |
|
|
2024
Q1 | $5.86M | Buy |
1,375,800
+104,300
| +8% | +$444K | 0.01% | 1314 |
|
|
2023
Q4 | $2.57M | Buy |
1,271,500
+142,311
| +13% | +$287K | ﹤0.01% | 1796 |
|
|
2023
Q3 | $1.73M | Sell |
1,129,189
-101,007
| -8% | -$155K | ﹤0.01% | 1950 |
|
|
2023
Q2 | $2.03M | Buy |
1,230,196
+711,396
| +137% | +$1.17M | ﹤0.01% | 1988 |
|
|
2023
Q1 | $591K | Buy |
518,800
+56,063
| +12% | +$63.9K | ﹤0.01% | 2793 |
|
|
2022
Q4 | $417K | Sell |
462,737
-438,063
| -49% | -$395K | ﹤0.01% | 3051 |
|
|
2022
Q3 | $1.05M | Sell |
900,800
-325,600
| -27% | -$381K | ﹤0.01% | 2466 |
|
|
2022
Q2 | $785K | Buy |
1,226,400
+1,192,100
| +3,476% | +$763K | ﹤0.01% | 2866 |
|
|
2022
Q1 | $90K | Buy |
34,300
+23,043
| +205% | +$60.5K | ﹤0.01% | 3812 |
|
|
2021
Q4 | $44K | Sell |
11,257
-178,412
| -94% | -$697K | ﹤0.01% | 3793 |
|
|
2021
Q3 | $827K | Sell |
189,669
-55,779
| -23% | -$243K | ﹤0.01% | 2651 |
|
|
2021
Q2 | $974K | Buy |
+245,448
| New | +$974K | ﹤0.01% | 2682 |
|
|
2021
Q1 | – | Sell |
-271,800
| Closed | -$1.45M | – | 3291 |
|
|
2020
Q4 | $1.45M | Buy |
+271,800
| New | +$1.45M | ﹤0.01% | 2306 |
|
|
2020
Q2 | – | Sell |
-294,051
| Closed | -$644K | – | 3418 |
|
|
2020
Q1 | $644K | Buy |
294,051
+215,051
| +272% | +$471K | ﹤0.01% | 2640 |
|
|
2019
Q4 | $460K | Buy |
+79,000
| New | +$460K | ﹤0.01% | 2936 |
|